Upload
others
View
4
Download
0
Embed Size (px)
Citation preview
Comprehensive Listing of Drugs in the USP Model Guidelines for Drugs Approved Through October 2004
This document provides a comprehensive listing of drugs categorized according to the USP Model Guidelines categories and classes. Although every effort has been made to include all eligible Part D, Food and Drug Administration (FDA)-approved dugs approved through October 2004 within each Therapeutic Category and Pharmacologic Class, the absence of a drug from this list does not specifically imply an intended exclusion. USP intends to modify and revise this comprehensive listing as part of its ongoing activity related to updating the Model Guidelines. This listing appears in an excel formatted table that includes five columns. The first two columns – Therapeutic Category and Pharmacologic Class – comprise the USP Model Guidelines. The third column lists the Formulary Key Drug Types, which were provided to CMS separately in USP’s comments on the CMS Draft Guidance regarding the formulary review process. The remaining two columns comprise the comprehensive listing of drugs requested by CMS and are entitled Pharmaceutical Preparations and Salts/Esters. Each drug, drawn from the FDA’s Orange Book, has been listed according to its generic name. USP understands that CMS intends to use the Formulary Key Drug Types as a check, assessing whether a formulary includes at least one drug from each item in the listing – or request justification for any exclusions. Because this will apply to all formularies, USP has included this listing here to facilitate CMS’ evaluation of formularies – regardless of the classification system that is used. Individual drugs are listed in the table based upon the most specifically listed Therapeutic Category, Pharmacologic Class or Formulary Key Drug Type. The enclosed table offers a foundation for a more comprehensive database that could be of great benefit to CMS, Plans, and to the overall administration of the Medicare Prescription Drug Benefit. As part of its ongoing work to revise the Model Guidelines, USP proposes to enhance this table over time to include valuable clinical and economic data such as:
• International Classification of Diseases, Ninth Revision Codes (ICD-9 Codes) • Off-label indications • Dosage forms • Route of administration • Pharmacokinetics • Patient population-based preferred drugs lists • The National Drug Code Directory Codes (NDC Codes) • Average pricing guides • And more.
This information could be utilized for individual plan and formulary analysis as well as for data collection and analysis for the overall benefit.
COMPREHENSIVE LISTING OF DRUGS IN THE USP MODEL GUIDELINESTherapeutic
CategoryPharmacologic
ClassFormulary Key
Drug TypesPharmaceutical
PreparationsSalts/Esters
Analgesics Opioid Analgesics Opioid Analgesics, Long-acting
Levomethadyl Acetate Hydrochloride
Levorphanol Tartrate
Methadone Hydrochloride
Morphine Sulfate
Opioid Analgesics, Short-acting
Alfentanil Hydrochloride
Buprenorphine
Butorphanol Tartrate
Codeine Phosphate
Sulfate
Fentanyl
Citrate
Hydromorphone Hydrochloride
Meperidine HydrochlorideNalbuphine Hydrochloride
Opium
Oxycodone Hydrochloride
Oxymorphone Hydrochloride
Pentazocine Lactate
Propoxyphene Hydrochloride
Napsylate
Remifentanil
Sufentanil Citrate
Tramadol Hydrochloride
Non-opioid Analgesics Cyclooxygenase-2 (COX-2) Inhibitors
Celecoxib
Valdecoxib
Nonsteroidal Anti-inflammatory Drugs, Nonspecific
Duloxetine Hydrochloride
Choline and Magnesium SalicylatesDiclofenac Potassium
Sodium
Diflunisal
Etodolac
Fenoprofen Calcium
Flurbiprofen
Ibuprofen
Indomethacin
Ketoprofen
Ketorolac Tromethamine
Magnesium Salicylate
Meclofenamate Sodium
Mefenamic Acid
Comprehensive Listing of Drugs in the USP Model Guidelinesfor Drugs Approved Through October 2004
Provided by: Indiana Health Coverage Programs (IHCP)TR287-ComprehensiveDrugListing2004.pdf Page 2 of 34
EDS - Indiana Title XIX950 N. Meridian St., Suite 1150
Indianapolis, IN 46204
Therapeutic Category
Pharmacologic Class
Formulary Key Drug Types
Pharmaceutical Preparations
Salts/Esters
Meloxicam
Nabumetone
Naproxen
Sodium
Oxaprozin
Piroxicam
Salsalate
Sodium Thiosalicylate
Sulindac
Tolmetin Sodium
Anesthetics Local Anesthetics
Articaine Hydrochloride
Bupivicaine Hydrochloride
Chloroprocaine Hydrochloride
Levobupivicaine
Lidocaine Hydrochloride
Mepivacaine Hydrochloride
Procaine Hydrochloride
Tetracaine Hydrochloride
Antibacterials Beta-lactam, Cephalosporins
Cephalosporin Antibacterials, 1st Generation
Cefadroxil
Cefazolin
Cephalexin
Hydrochloride
Cephapirin
Cephradine
Cephalosporin Antibacterials, 2nd Generation
Cefaclor
Cefamandole Nafate
Cefonicid
Cefotetan
Cefoxitin
Cefprozil
Cefuroxime Axetil
Cephalosporin Antibacterials, 3rd Generation
Cefdinir
Cefditoren
Cefixime
Cefoperazone
Cefotaxime
Cefpodoxime Proxetil
Ceftazidime
Ceftibuten
Ceftizoxime
Ceftriaxone
Beta-lactam, Penicillins Amino Derivative Penicillins
Amoxicillin
Amoxicillin and Clavulanate Potassium
Comprehensive Listing of Drugs in the USP Model Guidelinesfor Drugs Approved Through October 2004
Provided by: Indiana Health Coverage Programs (IHCP)TR287-ComprehensiveDrugListing2004.pdf Page 3 of 34
EDS - Indiana Title XIX950 N. Meridian St., Suite 1150
Indianapolis, IN 46204
Therapeutic Category
Pharmacologic Class
Formulary Key Drug Types
Pharmaceutical Preparations
Salts/Esters
Ampicillin
Sodium
Ampicillin and Sulbactam Sodium
Bacampicillin Hydrochloride
Extended Spectrum Penicillins
Carbenicillin Indanyl Sodium
Disodium
Mezlocillin Sodium
Piperacillin Sodium
Piperacillin and Tazobactam Sodium
Ticarcillin Disodium
Ticarcillin and Clavulanic Acid
Penicillinase-resistant Penicillins
Cloxacillin Sodium
Dicloxacillin Sodium
Flucloxacillin Sodium
Methicillin Sodium
Nafcillin Sodium
Oxacillin Sodium
Beta-lactam, Other Carbacephem Antibacterials
Loracarbef
Macrolides Erythromycins
Erythromycin
Estolate
Ethylsuccinate
Lactobionate
Stearate
Ketolides
Telithromycin
Macrolides (Non-erythromycins, Non-ketolides)
Azithromycin
Clarithromycin
Dirithromycin
Troleandomycin
Quinolones Quinolones, Fluorinated
Ciprofloxacin
Gatifloxacin
Gemifloxacin
Levofloxacin
Lomefloxacin
Moxifloxacin Hydrochloride
Norfloxacin
Ofloxacin
Quinolones, Non-fluorinated
Nalidixic Acid
Sulfonamides
Sulfadiazine
Comprehensive Listing of Drugs in the USP Model Guidelinesfor Drugs Approved Through October 2004
Provided by: Indiana Health Coverage Programs (IHCP)TR287-ComprehensiveDrugListing2004.pdf Page 4 of 34
EDS - Indiana Title XIX950 N. Meridian St., Suite 1150
Indianapolis, IN 46204
Therapeutic Category
Pharmacologic Class
Formulary Key Drug Types
Pharmaceutical Preparations
Salts/Esters
Sulfadiazine and TrimethoprimSulfamethizole
Sulfanilamide
Sulfisoxazole
Acetyl
Sulfamethoxazole and Trimethoprim
Tetracyclines
Demeclocycline Hydrochloride
Doxycycline
Calcium
Hyclate
Minocycline Hydrochloride
Oxytetracycline Hydrochloride
Tetracycline
Hydrochloride
Antibacterials, Other Antifolate Antibacterials
Trimethoprim
Glycopeptide Antibacterials
Vancomycin Hydrochloride
Lincomycin Antibacterials
Clindamycin Hydrochloride
Palmitate HydrochloridePhosphate
Lincomycin Hydrochloride
Nitrofuran Antibacterials
Furazolidone
Nitrofurantoin
Oxazolidinone Antibacterials
Linezolid
Miscellaneous Antibacterials
Bacitracin
Chloramphenicol
Palmitate
Daptomycin
Fosfomycin Tromethamine
Methenamine Hippurate
Mandelate
Metronidazole
Hydrochloride
Calcium
Neomycin Sulfate
Rifaximin
Spectinomycin Hydrochloride
Anticonvulsants Calcium Channel Modifying Agents
Ethosuximide
Methsuximide
Trimethadione
Comprehensive Listing of Drugs in the USP Model Guidelinesfor Drugs Approved Through October 2004
Provided by: Indiana Health Coverage Programs (IHCP)TR287-ComprehensiveDrugListing2004.pdf Page 5 of 34
EDS - Indiana Title XIX950 N. Meridian St., Suite 1150
Indianapolis, IN 46204
Therapeutic Category
Pharmacologic Class
Formulary Key Drug Types
Pharmaceutical Preparations
Salts/Esters
Zonisamide
Gamma-aminobutyric Acid (GABA) Augmenting Agents
Divalproex Sodium
Gabapentin
Primidone
Tiagabine Hydrochloride
Valproate Sodium
Valproic Acid
Glutamate Reducing Agents
Felbamate
Lamotrigine
Topiramate
Sodium Channel Inhibitors
Carbamazepine
Ethotoin
Fosphenytoin Sodium
Oxcarbazepine
Phenytoin Sodium
Anticonvulsants (Other)
Levetiracetam
Antidementia Agents Cholinesterase Inhibitors
Donepezil Hydrochloride
Galantamine
Rivastigmine Tartrate
Tacrine Hydrochloride
Glutamate Pathway Modifiers
Memantine
Antidementia Agents, Other
Ergoloid Mesylates
Antidepressants Monoamine Oxidase (Type A) Inhibitors
Phenelzine Sulfate
Tranylcypromine Sulfate
Reuptake Inhibitors Selective Serotonin Reuptake Inhibitors (SSRIs)
Citalopram Hydrobromide
Escitalopram Oxalate
Fluoxetine Hydrochloride
Fluvoxamine Maleate
Paroxetine Hydrochloride
Sertraline Hydrochloride
Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)
Duloxetine Hydrochloride
Nefazodone Hydrochloride
Venlafaxine Hydrochloride
Tricyclics
Amitriptyline Hydrochloride
Comprehensive Listing of Drugs in the USP Model Guidelinesfor Drugs Approved Through October 2004
Provided by: Indiana Health Coverage Programs (IHCP)TR287-ComprehensiveDrugListing2004.pdf Page 6 of 34
EDS - Indiana Title XIX950 N. Meridian St., Suite 1150
Indianapolis, IN 46204
Therapeutic Category
Pharmacologic Class
Formulary Key Drug Types
Pharmaceutical Preparations
Salts/Esters
Amoxapine
Clomipramine Hydrochloride
Desipramine Hydrochloride
Doxepin Hydrochloride
Imipramine Hydrochloride
Pamoate
Nortriptyline Hydrochloride
Protriptyline Hydrochloride
Trimipramine Maleate
Antidepressants, Other
Bupropion Hydrochloride
Maprotiline Hydrochloride
Mirtazapine
Trazodone Hydrochloride
Antiemetics 5-Hydroxytryptamine 3 (5-HT3) Antagonists
Dolasetron Mesylate
Granisetron Hydrochloride
Ondansetron Hydrochloride
Palonosetron Hydrochloride
Antiemetics (Non-5-HT3 Antagonists)
Aprepitant
Chlorpromazine Hydrochloride
Dimenhydrinate
Diphenhydramine Hydrochloride
Dronabinol
Droperidol
Hydroxyzine Pamoate
Meclizine Hydrochloride
Metoclopramide
Perphenazine
Prochlorperazine Edisylate
Maleate
Promethazine Hydrochloride
Scopolamine
Thiethylperazine Maleate
Trimethobenzamide Hydrochloride
Antifungals Allylamine Antifungals
Terbinafine Hydrochloride
Azole Antifungals
Butoconazole Nitrate
Clotrimazole
Fluconazole
Itraconazole
Ketoconazole
Miconazole Nitrate
Terconazole
Voriconazole
Polyene Antifungals
Amphotericin B
Comprehensive Listing of Drugs in the USP Model Guidelinesfor Drugs Approved Through October 2004
Provided by: Indiana Health Coverage Programs (IHCP)TR287-ComprehensiveDrugListing2004.pdf Page 7 of 34
EDS - Indiana Title XIX950 N. Meridian St., Suite 1150
Indianapolis, IN 46204
Therapeutic Category
Pharmacologic Class
Formulary Key Drug Types
Pharmaceutical Preparations
Salts/Esters
Amphotericin B Cholesteryl Complex
Sulfate
Amphotericin B Lipid ComplexAmphotericin B Liposomal ComplexNystatin
Pyrimidine Antifungals
Flucytosine
Antifungals (Other)
Griseofulvin
Antigout Agents Renal Tubular Blocking Agents
Probenecid
Sulfinpyrazone
Xanthine Oxidase Inhibitors
Allopurinol
Antigout Agents (Non-renal Tubular Blocking Agents and Non-xanthine Inhibitors)
Colchicine
Anti-inflammatories Glucocorticoids
Nonsteroidal Anti-inflammatory Drugs
Cyclooxygenase-2 (COX-2) Inhibitors
Celecoxib
Valdecoxib
Nonsteroidal Anti-inflammatory Drugs, Non-specific
Choline and Magnesium SalicylatesDiclofenac Potassium
Sodium
Diflunisal
Etodolac
Fenoprofen Calcium
Flurbiprofen
Ibuprofen
Indomethacin
Ketoprofen
Ketorolac Tromethamine
Magnesium Salicylate
Meclofenamate Sodium
Mefenamic Acid
Meloxicam
Nabumetone
Naproxen
Sodium
Oxaprozin
Piroxicam
Salsalate
Sodium Thiosalicylate
Sulindac
Tolmetin Sodium
Antimigraine Agents Abortive Ergot Alkaloids
Comprehensive Listing of Drugs in the USP Model Guidelinesfor Drugs Approved Through October 2004
Provided by: Indiana Health Coverage Programs (IHCP)TR287-ComprehensiveDrugListing2004.pdf Page 8 of 34
EDS - Indiana Title XIX950 N. Meridian St., Suite 1150
Indianapolis, IN 46204
Therapeutic Category
Pharmacologic Class
Formulary Key Drug Types
Pharmaceutical Preparations
Salts/Esters
Dihydroergotamine Mesylate
Ergotamine Tartrate
Triptans
Almotriptan
Frovatriptan Succinate
Naratriptan HydrochlorideRizatriptan Benzoate
Sumatriptan
ZolmitriptanProphylactic Beta-adrenergic Blocking
AgentsPropranolol Hydrochloride
Timolol Maleate
Antimigraine Agents, Prophylactic (Non–beta-adrenergic Blocking Agents)
Divalproex Sodium
Topiramate
Antimycobacterials Antituberculars
Aminosalicylate Sodium
Capreomycin Sulfate
Cycloserine
Ethambutol Hydrochloride
Ethionamide
Isoniazid
Pyrazinamide
Rifampin
Rifampin and Isoniazid
Rifampin, Isoniazid, and PyrazinamideRifapentine
Antimycobacterials, Other
Clofazimine
Dapsone
Rifabutin
Antineoplastics Alkylating Agents
Altretamine
Busulfan
Carmustine
Chlorambucil
Cyclophosphamide
Dacarbazine
Ifosfamide
Lomustine
Mechlorethamine Hydrochloride
Melphalan
Hydrochloride
Procarbazine Hydrochloride
Temozolomide
Thiotepa
Uracil Mustard
Antimetabolites
Azacitidine
Comprehensive Listing of Drugs in the USP Model Guidelinesfor Drugs Approved Through October 2004
Provided by: Indiana Health Coverage Programs (IHCP)TR287-ComprehensiveDrugListing2004.pdf Page 9 of 34
EDS - Indiana Title XIX950 N. Meridian St., Suite 1150
Indianapolis, IN 46204
Therapeutic Category
Pharmacologic Class
Formulary Key Drug Types
Pharmaceutical Preparations
Salts/Esters
Capecitabine
Cytarabine
Floxuridine
Fluorouracil
Gemcitabine
Hydroxyurea
Mercaptopurine
Methotrexate
Sodium
Pemetrexed Disodium
Pentostatin
Thioguanine
Immune Modulators and Vaccines
Aldesleukin
BCG Vaccine (Live)
Molecular Target Inhibitors
Bortezomib
Erlotinib
Gefitinib
Imatinib Mesylate
Tretinoin
Nucleoside Analogs
Cladribine
Fludarabine Phosphate
Protective Agents
Amifostine
Dexrazoxane
Leucovorin Calcium
Mesna
Rasburicase
Topoisomerase Inhibitors
Etoposide
Phosphate
Irinotecan Hydrochloride
Teniposide
Topotecan
Antineoplastics, Other
Arsenic Trioxide
Asparaginase
Bexarotene
Carboplatin
Cisplatin
Denileukin Diftitox
Oxaliplatin
Pegaspargase
Porfimer Sodium
Antiparasitics Anthelmintics
Albendazole
Ivermectin
Mebendazole
Comprehensive Listing of Drugs in the USP Model Guidelinesfor Drugs Approved Through October 2004
Provided by: Indiana Health Coverage Programs (IHCP)TR287-ComprehensiveDrugListing2004.pdf Page 10 of 34
EDS - Indiana Title XIX950 N. Meridian St., Suite 1150
Indianapolis, IN 46204
Therapeutic Category
Pharmacologic Class
Formulary Key Drug Types
Pharmaceutical Preparations
Salts/Esters
Praziquantel
Pyrantel Pamoate
Thiabendazole
Antiprotozoals Antimalarials
Atovaquone and Proguanil Hydrochloride
Chloroquine Phosphate
Hydrochloride
Hydroxychloroquine Sulfate
Iodoquinol
Mefloquine Hydrochloride
Primaquine Phosphate
Pyrimethamine
Quinine Sulfate
Sulfadoxine and Pyrimethamine
Antiprotozoals (Non-antimalarials)
Atovaquone
Nitazoxanide
Pentamidine Isethionate
Tinidazole
Trimetrexate Glucuronate
Pediculicides/Scabicides
Lindane
Malathion
Permethrin
Antiparkinson Agents Catechol O-methyltransferase (COMT) Inhibitors
Entacapone
Tolcapone
Dopamine AgonistsAmantadine Hydrochloride
Carbidopa
Carbidopa and Levodopa
Levodopa
Pergolide Mesylate
Pramipexole Dihydrochloride Monohydrate
Ropinirole Hydrochloride
Antiparkinson Agents, Other
Benztropine
Biperiden Hydrochloride
Bromocriptine
Diphenhydramine Hydrochloride
Procyclidine Hydrochloride
Selegiline Hydrochloride
Trihexyphenidyl Hydrochloride
Antipsychotics Non-phenothiazines
Haloperidol Decanoate
Lactate
Loxapine Succinate
Molindone Hydrochloride
Comprehensive Listing of Drugs in the USP Model Guidelinesfor Drugs Approved Through October 2004
Provided by: Indiana Health Coverage Programs (IHCP)TR287-ComprehensiveDrugListing2004.pdf Page 11 of 34
EDS - Indiana Title XIX950 N. Meridian St., Suite 1150
Indianapolis, IN 46204
Therapeutic Category
Pharmacologic Class
Formulary Key Drug Types
Pharmaceutical Preparations
Salts/Esters
Pimozide
Thiothixene Hydrochloride
Ziprasidone Hydrochloride
Mesylate
Non-phenothiazines/ Atypicals
Aripiprazole
Clozapine
Olanzapine
Quetiapine Fumarate
Risperidone
Phenothiazines
Chlorpromazine Hydrochloride
Fluphenazine Hydrochloride
Decanoate
Enanthate
Hydrochloride
Mesoridazine Besylate
Perphenazine
Prochlorperazine
Edisylate
Maleate
Thioridazine Hydrochloride
Trifluoperazine Hydrochloride
Antivirals Anti-cytomegalovirus (CMV) Agents
Cidofovir
Foscarnet Sodium
Ganciclovir
Sodium
Valganciclovir Hydrochloride
Antiherpetic Agents
Acyclovir
Famciclovir
Foscarnet Sodium
Valacyclovir Hydrochloride
Anti-human Immunodeficiency Virus (HIV) Agents, Fusion Inhibitors
Enfuvirtide
Anti-HIV Agents, Non-nucleoside Reverse Transcriptase Inhibitors
Delavirdine Mesylate
Efavirenz
Nevirapine
Anti-HIV Agents, Nucleoside and Nucleotide Reverse Transcriptase Inhibitors
Abacavir Sulfate
Comprehensive Listing of Drugs in the USP Model Guidelinesfor Drugs Approved Through October 2004
Provided by: Indiana Health Coverage Programs (IHCP)TR287-ComprehensiveDrugListing2004.pdf Page 12 of 34
EDS - Indiana Title XIX950 N. Meridian St., Suite 1150
Indianapolis, IN 46204
Therapeutic Category
Pharmacologic Class
Formulary Key Drug Types
Pharmaceutical Preparations
Salts/Esters
Abacavir, Lamivudine, and ZidovudineDidanosine
Emtricitabine
Emtricitabine and Tenofovir Disoproxil Fumarate
Lamivudine
Lamivudine and Zidovudine
Stavudine
Tenofovir Disoproxil Fumarate
Zalcitabine
Zidovudine
Anti-HIV Agents, Protease Inhibitors
Amprenavir
Atazanavir Sulfate
Fosamprenavir Calcium
Indinavir Sulfate
Lopinavir and Ritonavir
Nelfinavir Mesylate
Ritonavir
Saquinavir
Mesylate
Anti-influenza Agents
Amantadine Hydrochloride
Oseltamivir Phosphate
Rimantadine Hydrochloride
Zanamivir
Antivirals, Other
Adefovir Dipivoxil
Ribavirin
Anxiolytics Antidepressants
Doxepin Hydrochloride
Escitalopram Oxalate
Paroxetine Hydrochloride
Sertraline Hydrochloride
Anxiolytics, Other
Buspirone Hydrochloride
Meprobamate
Autonomic Agents Parasympatholytics
Atropine Sulfate
Belladonna
Dicyclomine Hydrochloride
Glycopyrrolate
Hyoscyamine
Sulfate
Mepenzolate Bromide
Methscopolamine Bromide
Orphenadrine Citrate
Propantheline Bromide
Scopolamine
Tolterodine Tartrate
Comprehensive Listing of Drugs in the USP Model Guidelinesfor Drugs Approved Through October 2004
Provided by: Indiana Health Coverage Programs (IHCP)TR287-ComprehensiveDrugListing2004.pdf Page 13 of 34
EDS - Indiana Title XIX950 N. Meridian St., Suite 1150
Indianapolis, IN 46204
Therapeutic Category
Pharmacologic Class
Formulary Key Drug Types
Pharmaceutical Preparations
Salts/Esters
Parasympathomimetics
Ambenonium Chloride
Edrophonium Chloride
Guanidine Hydrochloride
Neostigmine Methylsulfate
Pyridostigmine Bromide
Sympatholytics Alpha-adrenergic Blocking Agents
Alfuzosin Hydrochloride
Doxazosin Mesylate
Hydrochloride
Phenoxybenzamine Hydrochloride
Phentolamine Mesylate
Prazosin Hydrochloride
Tamsulosin Hydrochloride
Terazosin Hydrochloride
Beta-adrenergic Blocking Agents
Acebutolol Hydrochloride
Atenolol
Betaxolol Hydrochloride
Bisoprolol Fumarate
Carteolol Hydrochloride
Carvedilol
Esmolol Hydrochloride
Labetalol Hydrochloride
Hydrochloride
Metoprolol Tartrate
Succinate
Tartrate
Nadolol
Penbutolol Sulfate
Pindolol
Propranolol Hydrochloride
Sotalol Hydrochloride
Timolol Maleate
Sympathomimetics Alpha-adrenergic Agonists
Clonidine Hydrochloride
Guanabenz Acetate
Guanfacine Hydrochloride
Mephentermine Sulfate
Metaraminol Bitartrate
Methoxamine Hydrochloride
Methyldopa
Methyldopate Hydrochloride
Midodrine Hydrochloride
Phenylephrine Hydrochloride
Alpha-beta–adrenergic Agonists
Ephedrine Sulfate
Epinephrine Hydrochloride
Norepinephrine Bitartrate
Beta-adrenergic Agonists
Dobutamine Hydrochloride
Comprehensive Listing of Drugs in the USP Model Guidelinesfor Drugs Approved Through October 2004
Provided by: Indiana Health Coverage Programs (IHCP)TR287-ComprehensiveDrugListing2004.pdf Page 14 of 34
EDS - Indiana Title XIX950 N. Meridian St., Suite 1150
Indianapolis, IN 46204
Therapeutic Category
Pharmacologic Class
Formulary Key Drug Types
Pharmaceutical Preparations
Salts/Esters
Dopamine Hydrochloride
Dopamine/Dextrose Hydrochloride
Isoproterenol Hydrochloride
Bipolar Agents
Divalproex Sodium
Lithium Carbonate
Citrate
Ziprasidone Hydrochloride
Mesylate
Blood Glucose Regulators
Antihypoglycemics
Diazoxide
Glucagon Hydrochloride
Hypoglycemics, Oral Alpha Glucosidase Inhibitors
Acarbose
Miglitol
Biguanides
Metformin Hydrochloride
Meglitinides
Nateglinide
Repaglinide
Sulfonylureas
Acetohexamide
Chlorpropamide
Glimepiride
Glipizide
Glyburide
Tolazamide
Tolbutamide
Thiazolidinediones
Pioglitazone
Rosiglitazone Maleate
Insulins
Insulin, Rapid-acting
Insulin Aspart
Insulin Lispro
Insulin, Short-acting
Insulin (Purified pork)
Insulin Human
Insulin, Intermediate-acting
Insulin (Purified pork) Zinc
Insulin Human Zinc
Isophane Insulin (Beef/pork)
Isophane Insulin (Purified pork)Isophane Insulin Human
Insulin, Long-acting
Insulin Glargine
Insulin Human (Extended) Zinc
Blood Products/Modifiers/ Volume Expanders
Anticoagulants Anticoagulants, Oral
Anisindione
Comprehensive Listing of Drugs in the USP Model Guidelinesfor Drugs Approved Through October 2004
Provided by: Indiana Health Coverage Programs (IHCP)TR287-ComprehensiveDrugListing2004.pdf Page 15 of 34
EDS - Indiana Title XIX950 N. Meridian St., Suite 1150
Indianapolis, IN 46204
Therapeutic Category
Pharmacologic Class
Formulary Key Drug Types
Pharmaceutical Preparations
Salts/Esters
Warfarin Sodium
Blood Formation Products
Darbepoetin Alfa
Epoetin Alfa
Coagulants
Aminocaproic Acid
Antihemophilic Factor (Cryoprecipitated)Antihemophilic Factor (Human)Antihemophilic Factor (Porcine)Antihemophilic Factor (Recombinant)
Anti-inhibitor Coagulant ComplexAprotinin
Factor VIIa
Factor IX (Human)
Factor IX Complex (Human)
Phytonadione
Tranexamic Acid
Platelet Aggregation Inhibitors
Abciximab
Aspirin
Cilostazol
Clopidogrel Bisulfate
Dipyridamole
Eptifibatide
Ticlopidine Hydrochloride
Tirofiban Hydrochloride
Cardiovascular Agents
Alpha-adrenergic Agonists
Clonidine Hydrochloride
Guanabenz Acetate
Guanfacine Hydrochloride
Mephentermine Sulfate
Metaraminol Bitartrate
Methoxamine Hydrochloride
Methyldopa
Methyldopate Hydrochloride
Midodrine Hydrochloride
Phenylephrine Hydrochloride
Alpha-adrenergic Blocking Agents
Doxazosin Mesylate
Phenoxybenzamine Hydrochloride
Phentolamine Mesylate
Prazosin Hydrochloride
Terazosin Hydrochloride
Antiarrhythmics Antiarrhythmics - Classes IA, B, and C
Disopyramide Phosphate
Flecainide Acetate
Comprehensive Listing of Drugs in the USP Model Guidelinesfor Drugs Approved Through October 2004
Provided by: Indiana Health Coverage Programs (IHCP)TR287-ComprehensiveDrugListing2004.pdf Page 16 of 34
EDS - Indiana Title XIX950 N. Meridian St., Suite 1150
Indianapolis, IN 46204
Therapeutic Category
Pharmacologic Class
Formulary Key Drug Types
Pharmaceutical Preparations
Salts/Esters
Lidocaine Hydrochloride
Mexiletine Hydrochloride
Moricizine Hydrochloride
Procainamide Hydrochloride
Propafenone Hydrochloride
Quinidine Bisulfate
Gluconate
Polygalacturonate
Sulfate
Tocainide Hydrochloride
Antiarrhythmics - Class II
Acebutolol Hydrochloride
Esmolol Hydrochloride
Propranolol Hydrochloride
Antiarrhythmics - Class III
Amiodarone Hydrochloride
Bretylium Tosylate
Dofetilide
Ibutilide Fumarate
Sotalol Hydrochloride
Antiarrhythmics - Class IV
Bepridil Hydrochloride
Diltiazem Hydrochloride
Verapamil Hydrochloride
Antiarrhythmics (Other)
Adenosine Phosphate
Beta-adrenergic Blocking Agents
Alpha-beta–adrenergic Blocking Agents
Labetalol Hydrochloride
Carvedilol
Cardioselective Beta-adrenergic Blocking Agents
Acebutolol Hydrochloride
Atenolol
Betaxolol Hydrochloride
Bisoprolol Fumarate
Esmolol Hydrochloride
Metoprolol Succinate
Tartrate
Nonselective Beta-adrenergic Blocking Agents
Carteolol Hydrochloride
Nadolol
Penbutolol Sulfate
Pindolol
Propranolol Hydrochloride
Sotalol Hydrochloride
Timolol Maleate
Calcium Channel Blocking Agents
Dihydropyridines
Comprehensive Listing of Drugs in the USP Model Guidelinesfor Drugs Approved Through October 2004
Provided by: Indiana Health Coverage Programs (IHCP)TR287-ComprehensiveDrugListing2004.pdf Page 17 of 34
EDS - Indiana Title XIX950 N. Meridian St., Suite 1150
Indianapolis, IN 46204
Therapeutic Category
Pharmacologic Class
Formulary Key Drug Types
Pharmaceutical Preparations
Salts/Esters
Amlodipine
Felodipine
Isradipine
Nicardipine Hydrochloride
Nifedipine
Nimodipine
Nisoldipine
Calcium Channel Blocking Agents (Non-dihydropyridines)
Bepridil Hydrochloride
Diltiazem Hydrochloride
Verapamil Hydrochloride
Direct Cardiac Inotropics
Digoxin
Inamrinone Lactate
Milrinone Lactate
Diuretics Carbonic Anhydrase Inhibitors
Acetazolamide
Sodium
Methazolamide
Loop Diuretics
BumetanideEthacrynic Acid
Ethacrynate Sodium
Furosemide
TorsemideOsmotic Diuretics
Glycerin
Mannitol
Urea
Potassium-sparing Diuretics
Amiloride Hydrochloride
Triamterene
Thiazide Diuretics
Bendroflumethiazide
ChlorothiazideSodium
Chlorthalidone
HydrochlorothiazideHydroflumethiazide
Indapamide
MethyclothiazideMetolazone
Polythiazide
TrichlormethiazideDyslipidemics Bile Acid Sequestrants
Cholestyramine Resin
Colesevelam Hydrochloride
Colestipol Hydrochloride
Fibrates
Clofibrate
Comprehensive Listing of Drugs in the USP Model Guidelinesfor Drugs Approved Through October 2004
Provided by: Indiana Health Coverage Programs (IHCP)TR287-ComprehensiveDrugListing2004.pdf Page 18 of 34
EDS - Indiana Title XIX950 N. Meridian St., Suite 1150
Indianapolis, IN 46204
Therapeutic Category
Pharmacologic Class
Formulary Key Drug Types
Pharmaceutical Preparations
Salts/Esters
Fenofibrate
Gemfibrozil
3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) Reductase Inhibitors
Atorvastatin Calcium
Fluvastatin Sodium
Lovastatin
Pravastatin SodiumRosuvastatin Calcium
SimvastatinLipid Absorption Inhibitors
Ezetimibe
Nicotinic Acid
Niacin
Renin-angiotensin-aldosterone System Inhibitors
Aldosterone Receptor Antagonists
Eplerenone
SpironolactoneAngiotensin-converting Enzyme (ACE) Inhibitors
Benazepril Hydrochloride
Captopril
Enalapril Maleate
Enalaprilat
Fosinopril Sodium
Lisinopril
Moexipril Hydrochloride
Perindopril Erbumine
Quinapril Hydrochloride
Ramipril
Trandolapril
Angiotensin II Receptor Antagonists
Candesartan Cilexetil
Eprosartan Mesylate
Irbesartan
Losartan Potassium
Olmesartan Medoxomil
Telmisartan
Valsartan
Vasodilators
Amyl Nitrite
Bosentan
Diazoxide
Epoprostenol Sodium
Ethaverine Hydrochloride
Fenoldopam Mesylate
Hydralazine Hydrochloride
Isosorbide Dinitrate
Mononitrate
Comprehensive Listing of Drugs in the USP Model Guidelinesfor Drugs Approved Through October 2004
Provided by: Indiana Health Coverage Programs (IHCP)TR287-ComprehensiveDrugListing2004.pdf Page 19 of 34
EDS - Indiana Title XIX950 N. Meridian St., Suite 1150
Indianapolis, IN 46204
Therapeutic Category
Pharmacologic Class
Formulary Key Drug Types
Pharmaceutical Preparations
Salts/Esters
Isoxsuprine Hydrochloride
Minoxidil
Papaverine Hydrochloride
Nesiritide
Nitroglycerin
Nitroprusside Sodium
Treprostinil Sodium
Central Nervous System Agents
Amphetamines
Dextroamphetamine Sulfate
Dextroamphetamine and Amphetamine
(Mixed salts)
Methamphetamine Hydrochloride
Non-amphetamines
Atomoxetine Hydrochloride
Dexmethylphenidate Hydrochloride
Doxapram Hydrochloride
Methylphenidate Hydrochloride
Modafinil
Pemoline
Riluzole
Dental and Oral Agents
Amlexanox
Cevimeline Hydrochloride
Chlorhexidine Gluconate
Doxycycline Hyclate
Minocycline
Palifermin
Pilocarpine Hydrochloride
Prilocaine Hydrochloride
Triamcinolone Acetonide
Dermatological Agents
Dermatological Anesthetics
Cocaine Hydrochloride
Lidocaine
Hydrochloride
Tetracaine Hydrochloride
Dermatological Antibacterials
Gentamicin Sulfate
Mafenide Acetate
Metronidazole
Mupirocin
Calcium
Silver Sulfadiazine
Dermatological Antifungals
Amphotericin B
Butenafine
Ciclopirox
Clotrimazole
Econazole Nitrate
Ketoconazole
Miconazole Nitrate
Comprehensive Listing of Drugs in the USP Model Guidelinesfor Drugs Approved Through October 2004
Provided by: Indiana Health Coverage Programs (IHCP)TR287-ComprehensiveDrugListing2004.pdf Page 20 of 34
EDS - Indiana Title XIX950 N. Meridian St., Suite 1150
Indianapolis, IN 46204
Therapeutic Category
Pharmacologic Class
Formulary Key Drug Types
Pharmaceutical Preparations
Salts/Esters
Naftifine Hydrochloride
Nystatin
Oxiconazole Nitrate
Sertaconazole Nitrate
Sulconazole Nitrate
Terbinafine Hydrochloride
Dermatological Anti-inflammatories
Diclofenac Sodium
Dermatological Antipruritic Agents
Doxepin Hydrochloride
Pramoxine and Hydrocortisone
Hydrochloride and Acetate
Dermatological Antivirals
Acyclovir
Penciclovir Sodium
Dermatological Keratolytics
Dermatological Mitotic Inhibitors
Chloroxine
Podofilox
Podophyllum Resin
Selenium Sulfide
Dermatological Photochemotherapy Agents
Porphyrin Derivative Photochemotherapy
Aminolevulinic Acid Hydrochloride
Psoralen Photochemotherapy
Methoxsalen
Trioxsalen
Dermatological Retinoids
Acitretin
Alitretinoin
Tazarotene
Tretinoin
Dermatological Tar Derivatives
Anthralin
Dermatological Vitamin D Analogs
Calcipotriene
Dermatological Wound Care Agents
Becaplermin
Wound Debriding Agents
CollagenaseDeterrents/ Replacements
Alcohol Deterrents
Acamprosate Calcium
Disulfiram
Enzyme Replacements/ Modifiers
Agalsidase Beta
Alglucerase
Comprehensive Listing of Drugs in the USP Model Guidelinesfor Drugs Approved Through October 2004
Provided by: Indiana Health Coverage Programs (IHCP)TR287-ComprehensiveDrugListing2004.pdf Page 21 of 34
EDS - Indiana Title XIX950 N. Meridian St., Suite 1150
Indianapolis, IN 46204
Therapeutic Category
Pharmacologic Class
Formulary Key Drug Types
Pharmaceutical Preparations
Salts/Esters
Betaine Anhydrous
Cysteamine Bitartrate
Imiglucerase
Laronidase
Miglustat
Nitisinone
Pancrelipase
Pegademase Bovine
Sacrosidase
Sodium PhenylbutyrateGastrointestinal Agents
Antispasmodics, Gastrointestinal
Atropine Sulfate
Belladonna
Dicyclomine Hydrochloride
Glycopyrrolate
Hyoscyamine
Sulfate
Mepenzolate Bromide
Methscopolamine Bromide
Propantheline Bromide
Scopolamine
Histamine2 (H2) Blocking Agents
Cimetidine
Hydrochloride
Famotidine
Nizatidine
Ranitidine Hydrochloride
Irritable Bowel Syndrome Agents
Alosetron
Tegaserod Maleate
Protectants
Misoprostol
Sucralfate
Proton Pump Inhibitors
Esomeprazole Magnesium
Lansoprazole
Omeprazole
Pantoprazole Sodium
Sodium Sesquihydrate
Rabeprazole
Gastrointestinal Agents, Other
Cisapride
Dehydrocholic Acid
Difenoxin and Atropine Hydrochloride and Sulfate
Diphenoxylate and Atropine Hydrochloride and Sulfate
Lactulose
Lanthanum Carbonate
Loperamide Hydrochloride
Comprehensive Listing of Drugs in the USP Model Guidelinesfor Drugs Approved Through October 2004
Provided by: Indiana Health Coverage Programs (IHCP)TR287-ComprehensiveDrugListing2004.pdf Page 22 of 34
EDS - Indiana Title XIX950 N. Meridian St., Suite 1150
Indianapolis, IN 46204
Therapeutic Category
Pharmacologic Class
Formulary Key Drug Types
Pharmaceutical Preparations
Salts/Esters
Octreotide
Polyethylene Glycol 3350 NF
Sevelamer Hydrochloride
Ursodiol
Genitourinary Agents Antispasmodics, Urinary
Darifenacin
Flavoxate Hydrochloride
Hyoscyamine
Sulfate
Oxybutynin
Chloride
Solifenacin Succinate
Tolterodine Tartrate
Trospium Chloride
Benign Prostatic Hypertrophy Agents
Alpha1-adrenergic Blocking Agents
Alfuzosin Hydrochloride
Doxazosin Mesylate
Tamsulosin Hydrochloride
Terazosin Hydrochloride
5 Alpha-reductase Inhibitors
Dutasteride
Finasteride
Impotence Agents Phosphodiesterase Inhibitors
Sildenafil CitrateTadalafil
Vardenafil HydrochlorideProstaglandins
Alprostadil
Hormonal Agents, Stimulant/ Replacement/ Modifying
Adrenal Glucocorticoids
Betamethasone
Sodium Phosphate
Sodium Phosphate and Acetate
Budesonide
Cortisone Acetate
Dexamethasone
Acetate
Sodium Phosphate
Hydrocortisone
Acetate
Sodium Phosphate
Sodium Succinate
Methylprednisolone
Acetate
Sodium Succinate
Prednisolone
Acetate
Comprehensive Listing of Drugs in the USP Model Guidelinesfor Drugs Approved Through October 2004
Provided by: Indiana Health Coverage Programs (IHCP)TR287-ComprehensiveDrugListing2004.pdf Page 23 of 34
EDS - Indiana Title XIX950 N. Meridian St., Suite 1150
Indianapolis, IN 46204
Therapeutic Category
Pharmacologic Class
Formulary Key Drug Types
Pharmaceutical Preparations
Salts/Esters
Acetate and Sodium PhosphateSodium Phosphate
Prednisone
Triamcinolone
Acetonide
Diacetate
Hexacetonide
Glucocorticoids-Topical-Low Potency
Alclometasone Dipropionate
Cloclortolone Pivalate
Desonide
Dexamethasone
Sodium Phosphate
Flumethasone Pivalate
Hydrocortisone
Acetate
Glucocorticoids-Topical-Medium Potency
Betamethasone Benzoate
Valerate
Desoximetasone
Fluocinolone Acetonide
Flurandrenolide
Fluticasone Propionate
Hydrocortisone Butyrate
Probutate
Valerate
Mometasone Furoate
Prednicarbate
Triamcinolone Acetonide
Glucocorticoids-Topical-High Potency
Amcinonide
Betamethasone
Dipropionate
Desoximetasone
Diflorasone Diacetate
Fluocinolone Acetonide
Fluocinonide
Halcinonide
Triamcinolone Acetonide
Glucocorticoids-Topical-Very High Potency
Betamethasone Dipropionate
Clobetasol Propionate
Diflorasone Diacetate
Halobetasol Propionate
Mineralocorticoids
Fludrocortisone Acetate
Parathyroid/Metabolic Bone Disease Agents
Bisphosphonates
Alendronate Sodium
Etidronate Disodium
Comprehensive Listing of Drugs in the USP Model Guidelinesfor Drugs Approved Through October 2004
Provided by: Indiana Health Coverage Programs (IHCP)TR287-ComprehensiveDrugListing2004.pdf Page 24 of 34
EDS - Indiana Title XIX950 N. Meridian St., Suite 1150
Indianapolis, IN 46204
Therapeutic Category
Pharmacologic Class
Formulary Key Drug Types
Pharmaceutical Preparations
Salts/Esters
Pamidronate Disodium
Risedronate Sodium
Tiludronate Disodium
Zoledronic Acid
Calcium Regulating Hormones
Calcitonin, Salmon
Teriparatide
Vitamin D–related Agents/Metabolic Bone Disease Agents
Doxercalciferol
Paricalcitol
Parathyroid/Metabolic Bone Disease Agents (Other)
Gallium Nitrate
Pituitary
Chorionic Gonadotropin
Desmopressin Acetate
Oxytocin
Somatrem
Somatropin, Recombinant
Vasopressin
Prostaglandins
Alprostadil
Carboprost Tromethamine
Dinoprostone
Misoprostol
Sex Hormones/Modifiers Androgens/Anabolic Steroids
Danazol
Fluoxymesterone
Methyltestosterone
Nandrolone Decanoate
Phenpropionate
Oxandrolone
Oxymetholone
Testosterone
Cypionate
Enanthate
Propionate
EstrogensDienestrol
Estradiol
Acetate
Cypionate
Hemihydrate
Valerate
Estrogens, Conjugated
Estrogens, Conjugated SyntheticEstrogens, Esterified
Estrone
Estropipate
Comprehensive Listing of Drugs in the USP Model Guidelinesfor Drugs Approved Through October 2004
Provided by: Indiana Health Coverage Programs (IHCP)TR287-ComprehensiveDrugListing2004.pdf Page 25 of 34
EDS - Indiana Title XIX950 N. Meridian St., Suite 1150
Indianapolis, IN 46204
Therapeutic Category
Pharmacologic Class
Formulary Key Drug Types
Pharmaceutical Preparations
Salts/Esters
Ethinyl Estradiol
Progestins
Hydroxyprogesterone Caproate
Levonogestrel
Medroxyprogesterone Acetate
Megestrol Acetate
Norethindrone
Acetate
Norgestrel
Progesterone
Selective Estrogen Receptor Modifying Agents
Raloxifene Hydrochloride
Thyroid
Levothyroxine Sodium
Liothyronine Sodium
Liotrix
Thyroid
Hormonal Agents, Suppressant
Adrenal
Aminoglutethimide
Mitotane
Pituitary
Abarelix
Bromocriptine Mesylate
Cabergoline
Goserelin Acetate
Histrelin Acetate
Leuprolide Acetate
Nafarelin Acetate
Octreotide Acetate
Pegvisomant
Triptorelin Pamoate
Sex Hormones/Modifiers Antiandrogens
Bicalutamide
Dutasteride
Finasteride
Flutamide
Nilutamide
Antiestrogens/Modifiers
Anastrozole
Estramustine Phosphate Sodium
Exemestane
Fulvestrant
Letrozole
Tamoxifen Citrate
Testolactone
Toremifene Citrate
Thyroid
Methimazole
PropylthiouracilParathyroid
Comprehensive Listing of Drugs in the USP Model Guidelinesfor Drugs Approved Through October 2004
Provided by: Indiana Health Coverage Programs (IHCP)TR287-ComprehensiveDrugListing2004.pdf Page 26 of 34
EDS - Indiana Title XIX950 N. Meridian St., Suite 1150
Indianapolis, IN 46204
Therapeutic Category
Pharmacologic Class
Formulary Key Drug Types
Pharmaceutical Preparations
Salts/Esters
Cinacalcet Hydrochloride
Immunological Agents Immune Stimulants Vaccines
Anthrax Vaccine Adsorbed
Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed
Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine
Haemophilus B Conjugate VaccineHaemophilus B Conjugate Vaccine and Hepatitis B Vaccine (Recombinant)
Hepatitis A Vaccine Inactivated
Hepatitis A Virus Vaccine Inactivated and Hepatitis B Virus Vaccine Recombinant
Hepatitis B Virus Vaccine Inactivated
Hepatitis B Virus Vaccine Recombinant
Influenza Virus Vaccine
Japanese Encephalitis Virus Vaccine Inactivated
Lyme Disease Vaccine
Measles Virus Vaccine Live
Measles, Mumps, and Rubella Virus Vaccine Live
Meningococcal Polysaccharide Vaccine
Mumps Virus Vaccine Live
Pneumococcal Conjugate Vaccine
Pneumococcal Vaccine Polyvalent
Comprehensive Listing of Drugs in the USP Model Guidelinesfor Drugs Approved Through October 2004
Provided by: Indiana Health Coverage Programs (IHCP)TR287-ComprehensiveDrugListing2004.pdf Page 27 of 34
EDS - Indiana Title XIX950 N. Meridian St., Suite 1150
Indianapolis, IN 46204
Therapeutic Category
Pharmacologic Class
Formulary Key Drug Types
Pharmaceutical Preparations
Salts/Esters
Poliovirus Vaccine Inactivated
Poliovirus Vaccine Live Oral
Rabies Vaccine
Rubella Virus Vaccine
Typhoid Vaccine Live Oral
Typhoid Vi Polysaccharide VaccineVaricella Virus Vaccine
Yellow Fever Vaccine
Immune Stimulants (Non-vaccines)
Interferon Alfa-2a, RecombinantInterferon Alfa-2b, RecombinantInterferon Alfa-n3
Interferon Alfacon-1
Interferon Beta-1a
Interferon Beta-1b
Interferon Gamma-1b, RecombinantPeginterferon Alfa-2b
Peginterferon Alfa-2a
Ribavirin and Interferon Alfa-2b
Immune Suppressants Tumor Necrosis Factor (TNF) Inhibitors
Adalimumab
Etanercept
Infliximab
Immune Suppressants (Non-TNF Inhibitors)
Alefacept
Anakinra
Azathioprine
Sodium
Basilixumab
Cyclosporine
Daclizumab
Efalizumab
Muromonab-CD3
Mycophenolate Mofetil
Mofetil Hydrochloride
Natalizumab
Penicillamine
Sirolimus
Tacrolimus
Immunomodulators
Auranofin
Glatiramer Acetate
Gold Sodium thiomalate
Imiquimod
Leflunomide
Omalizumab
Comprehensive Listing of Drugs in the USP Model Guidelinesfor Drugs Approved Through October 2004
Provided by: Indiana Health Coverage Programs (IHCP)TR287-ComprehensiveDrugListing2004.pdf Page 28 of 34
EDS - Indiana Title XIX950 N. Meridian St., Suite 1150
Indianapolis, IN 46204
Therapeutic Category
Pharmacologic Class
Formulary Key Drug Types
Pharmaceutical Preparations
Salts/Esters
Pimecrolimus
Tacrolimus
ThalidomideInflammatory Bowel Disease Agents
Glucocorticoids
Betamethasone
Sodium Phosphate and Acetate
Budesonide
Cortisone Acetate
Dexamethasone
Acetate
Sodium Phosphate
Hydrocortisone
Acetate
Sodium Succinate
Sodium Phosphate
Methylprednisolone
Acetate
Sodium Succinate
Prednisolone
Acetate
Acetate and Sodium PhosphateSodium Phosphate
Prednisone
Triamcinolone
Acetonide
Diacetate
SalicylatesBalsalazide Disodium
Mesalamine
Olsalazine Sodium
SulfonamidesSulfasalazine
Ophthalmic Agents Ophthalmic Anti-allergy Agents
Azelastine Hydrochloride
Cromolyn Sodium
Emedastine Difumarate
Ketotifen Fumarate
Levocabastine Hydrochloride
Lodoxamide Tromethamine
Naphazoline Hydrochloride
Nedocromil Sodium
Olopatadine Hydrochloride
Pemirolast Potassium
Ophthalmic Antibacterials
Bacitracin
Chloramphenicol
Ciprofloxacin Hydrochloride
Gentamicin Sulfate
Erythromycin
Comprehensive Listing of Drugs in the USP Model Guidelinesfor Drugs Approved Through October 2004
Provided by: Indiana Health Coverage Programs (IHCP)TR287-ComprehensiveDrugListing2004.pdf Page 29 of 34
EDS - Indiana Title XIX950 N. Meridian St., Suite 1150
Indianapolis, IN 46204
Therapeutic Category
Pharmacologic Class
Formulary Key Drug Types
Pharmaceutical Preparations
Salts/Esters
Gatifloxacin
Levofloxacin
Moxifloxacin Hydrochloride
Natamycin
Ofloxacin
Sulfacetamide Sodium
Tobramycin
Ophthalmic Antifungals
Natamycin
Ophthalmic Antiglaucoma Agents
Alpha-adrenergic Agonists, Ophthalmic
Apraclonidine Hydrochloride
Brimonidine
Dipivefrin Hydrochloride
Beta-adrenergic Blocking Agents, Ophthalmic
Betaxolol Hydrochloride
Carteolol Hydrochloride
Levobetaxolol Hydrochloride
Levobunolol Hydrochloride
Metipranolol Hydrochloride
Timolol Hemihydrate
Maleate
Carbonic Anhydrase Inhibitors, Ophthalmic
Acetazolamide
Sodium
Brinzolamide
Dorzolamide Hydrochloride
Methazolamide
Miotics, Ophthalmic
Carbachol
Demecarium Bromide
Echothiophate Iodide
Physostigmine Salicylate
Sulfate
Pilocarpine
Hydrochloride
Nitrate
Osmotic Agents, Ophthalmic
Glycerin
Mannitol
Urea
Prostaglandins, Ophthalmic
Bimatoprost
Latanoprost
Travoprost
Unoprostone Isopropyl
Ophthalmic Anti-inflammatories
Dexamethasone
Sodium Phosphate
Diclofenac Sodium
Comprehensive Listing of Drugs in the USP Model Guidelinesfor Drugs Approved Through October 2004
Provided by: Indiana Health Coverage Programs (IHCP)TR287-ComprehensiveDrugListing2004.pdf Page 30 of 34
EDS - Indiana Title XIX950 N. Meridian St., Suite 1150
Indianapolis, IN 46204
Therapeutic Category
Pharmacologic Class
Formulary Key Drug Types
Pharmaceutical Preparations
Salts/Esters
Fluorometholone
Acetate
Flurbiprofen Sodium
Ketorolac Tromethamine
Loteprednol
Medrysone
Prednisolone Acetate
Sodium Phosphate
Rimexolone
Ophthalmic Antivirals
Ganciclovir
Idoxuridine
Trifluridine
Ophthalmic Agents, Other
Botulinum Toxin Type A
Cyclosporine
Dapiprazole HydrochlorideFomiversen Sodium
Hydroxypropyl Cellulose
Pegaptanib Sodium
Verteporfin
Otic Agents Otic Antibacterials
Ofloxacin
Otic Anti-inflammatories
Dexamethasone Sodium Phosphate
Respiratory Tract Agents
Antihistamines Histamine1 (H1) Blocking Agents, Mildly/Non-sedating
Azelastine
Cetirizine Hydrochloride
Desloratadine
Fexofenadine Hydrochloride
H1 Blocking Agents, Sedating
Brompheniramine Maleate
Chlorpheniramine Maleate
Clemastine Fumarate
Dexchlorpheniramine Maleate
Dimenhydrinate
Diphenhydramine Hydrochloride
Promethazine Hydrochloride
Hydroxyzine Hydrochloride
Pamoate
Azatadine Maleate
Cyproheptadine Hydrochloride
Antileukotrienes
Montelukast Sodium
Zafirlukast
Zileuton
Bronchodilators, Anticholinergic
Ipratropium Bromide
Comprehensive Listing of Drugs in the USP Model Guidelinesfor Drugs Approved Through October 2004
Provided by: Indiana Health Coverage Programs (IHCP)TR287-ComprehensiveDrugListing2004.pdf Page 31 of 34
EDS - Indiana Title XIX950 N. Meridian St., Suite 1150
Indianapolis, IN 46204
Therapeutic Category
Pharmacologic Class
Formulary Key Drug Types
Pharmaceutical Preparations
Salts/Esters
Tiotropium Bromide Monohydrate
Bronchodilators, Anti-inflammatories
Beclomethasone Dipropionate
Dipropionate Monohydrate
Budesonide
Dexamethasone Sodium PhosphateFlunisolide
Fluticasone Propionate
Mometasone Furoate Monohydrate
Triamcinolone Acetonide
Bronchodilators, Phosphodiesterase 2 Inhibitors (Xanthines)
Aminophylline
Dyphylline
Oxytriphylline
Theophylline
Bronchodilators, Sympathomimetic
Albuterol Sulfate
Ephedrine Sulfate
Epinephrine
Bitartrate
Formoterol Fumarate Dihydrate
Isoetharine
Isoproterenol Hydrochloride
Levalbuterol Hydrochloride
Metaproterenol Sulfate
Pirbuterol Acetate
Salmeterol Xinafoate
Terbutaline Sulfate
Mast Cell Stabilizers
Cromolyn Sodium
Nedrocromil
Mucolytics
N-Acetylcysteine
Dornase Alfa
Respiratory Tract Agents, Other
Alpha 1-proteinase Inhibitor, HumanBenzonatate
Bosentan
Guaifenesin
Iodinated Glycerol
Oxygen
Potassium Iodide
Tetrahydrozoline Hydrochloride
Sedatives/ Hypnotics
Chloral Hydrate
Eszopiclone
Zaleplon
Comprehensive Listing of Drugs in the USP Model Guidelinesfor Drugs Approved Through October 2004
Provided by: Indiana Health Coverage Programs (IHCP)TR287-ComprehensiveDrugListing2004.pdf Page 32 of 34
EDS - Indiana Title XIX950 N. Meridian St., Suite 1150
Indianapolis, IN 46204
Therapeutic Category
Pharmacologic Class
Formulary Key Drug Types
Pharmaceutical Preparations
Salts/Esters
Zolpidem Tartrate
Skeletal Muscle Relaxants
Atracurium Besylate
Baclofen
Botulinum Toxin Type A
Botulinum Toxin Type B
Carisoprodol
Chlorphenesin Carbamate
Chlorzoxazone
Cisatracurium
Cyclobenzaprine Hydrochloride
Dantrolene Sodium
Doxacurium Chloride
Metaxalone
Methocarbamol
Orphenadrine Citrate
Hydrochloride
Pancuronium Bromide
Rocuronium Bromide
Succinylcholine Chloride
Tizanidine Hydrochloride
Vecuronium Bromide
Therapeutic Nutrients/Minerals/Electrolytes
Electrolytes/Minerals
Ammonium ChlorideCalcium Acetate
Chloride
Gluceptate
Gluconate
Chromic Chloride
Cupric Chloride
Sulfate
Fluoride
Sodium
Stannous
Strong Iodine
Iron Dextran
PolysaccharideSucrose
Magnesium Chloride
Sulfate
Manganese Chloride
Molybdate Ammonium
Potassium AcetateBicarbonate
Bicarbonate and CitrateChloride
Citrate
Citrate and Citric AcidGluconate
Comprehensive Listing of Drugs in the USP Model Guidelinesfor Drugs Approved Through October 2004
Provided by: Indiana Health Coverage Programs (IHCP)TR287-ComprehensiveDrugListing2004.pdf Page 33 of 34
EDS - Indiana Title XIX950 N. Meridian St., Suite 1150
Indianapolis, IN 46204
Therapeutic Category
Pharmacologic Class
Formulary Key Drug Types
Pharmaceutical Preparations
Salts/Esters
Gluconate and ChlorideGluconate and CitratePhosphates
Potassium, Monobasic Phosphates
Potassium and Sodium Citrates
Phosphates
Selenium
Sodium Acetate
Bicarbonate
Lactate
Chloride
Ferric Gluconate Complex
Phosphates
Tricitrates
Trikates
Zinc Chloride
Sulfate
Vitamins Prenatal Vitamins
Toxicologic Agents Opioid Antagonists
Nalmefene Hydrochloride
Naloxone Hydrochloride
Naltrexone Hydrochloride
Comprehensive Listing of Drugs in the USP Model Guidelinesfor Drugs Approved Through October 2004
Provided by: Indiana Health Coverage Programs (IHCP)TR287-ComprehensiveDrugListing2004.pdf Page 34 of 34
EDS - Indiana Title XIX950 N. Meridian St., Suite 1150
Indianapolis, IN 46204